Total Payments
$2,774
2024 Payments
$145.82
Companies
25
Transactions
182
Medicare Patients
1,630
Medicare Billing
$114,193
Payment Breakdown by Category
Food & Beverage$2,742 (98.9%)
Education$31.64 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,742 | 179 | 98.9% |
| Education | $31.64 | 3 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $652.17 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $492.33 | 25 | $0 (2018) |
| PFIZER INC. | $231.18 | 20 | $0 (2024) |
| Lilly USA, LLC | $228.50 | 21 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $204.25 | 11 | $0 (2018) |
| EISAI INC. | $139.58 | 11 | $0 (2022) |
| GlaxoSmithKline, LLC. | $126.57 | 9 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $118.07 | 11 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $117.63 | 8 | $0 (2018) |
| Amgen Inc. | $72.25 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.82 | 5 | Exact Sciences Corporation ($63.46) |
| 2023 | $87.12 | 3 | Novo Nordisk Inc ($66.05) |
| 2022 | $64.51 | 2 | Novo Nordisk Inc ($49.49) |
| 2021 | $20.03 | 1 | Eisai Inc. ($20.03) |
| 2019 | $110.71 | 3 | Novo Nordisk Inc ($110.71) |
| 2018 | $1,453 | 105 | AstraZeneca Pharmaceuticals LP ($299.56) |
| 2017 | $892.91 | 63 | AstraZeneca Pharmaceuticals LP ($192.77) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: Cranial Orthotic | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Obesity | ||||||
| 08/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $63.46 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $48.54 | General |
| Category: Obesity | ||||||
| 10/10/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Obesity | ||||||
| 08/10/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes Care | ||||||
| 12/01/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $49.49 | General |
| Category: Obesity | ||||||
| 01/10/2022 | EISAI INC. | Aduhelm (Drug) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Neurology | ||||||
| 10/19/2021 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| 12/09/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: Diabetes | ||||||
| 02/07/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $101.41 | General |
| Category: Obesity | ||||||
| 01/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: Diabetes | ||||||
| 12/24/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/20/2018 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Neuroscience | ||||||
| 12/17/2018 | Eisai Inc. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $11.87 | General |
| Category: Nutrition and Weight Loss | ||||||
| 12/12/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Virology & Specialty Care | ||||||
| 12/11/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Diabetes | ||||||
| 12/06/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Obesity | ||||||
| 12/04/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: VACCINE | ||||||
| 12/03/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Diabetes | ||||||
| 12/03/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: Diabetes | ||||||
| 11/27/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, COLOGUARD | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/27/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, COLOGUARD | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 224 | 367 | $73,158 | $22,185 |
| 2022 | 11 | 313 | 511 | $80,637 | $28,061 |
| 2021 | 12 | 395 | 610 | $83,937 | $31,926 |
| 2020 | 10 | 698 | 898 | $99,785 | $32,021 |
Total Patients
1,630
Total Services
2,386
Medicare Billing
$114,193
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 189 | $54,999 | $14,837 | 27.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $10,780 | $5,253 | 48.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,911 | $828.35 | 43.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 55 | $2,915 | $523.60 | 18.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $784.00 | $408.38 | 52.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 17 | 20 | $800.00 | $152.20 | 19.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 16 | 17 | $510.00 | $96.22 | 18.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 16 | 17 | $459.00 | $86.36 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 198 | $47,236 | $15,095 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $12,005 | $6,007 | 50.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $8,904 | $3,061 | 34.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 17 | 17 | $1,751 | $1,124 | 64.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 39 | 75 | $3,975 | $709.71 | 17.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $1,120 | $560.80 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,925 | $496.45 | 25.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $708.00 | $337.33 | 47.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 27 | 45 | $1,145 | $250.72 | 21.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 27 | 45 | $1,010 | $224.92 | 22.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 20 | 26 | $858.00 | $192.77 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 215 | $50,095 | $17,644 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $11,515 | $5,997 | 52.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 21 | $6,552 | $3,073 | 46.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 16 | 16 | $1,344 | $996.45 | 74.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 53 | 54 | $3,240 | $987.82 | 30.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 41 | 80 | $3,352 | $776.80 | 23.2% |
About Dr. Brian Cain, M.D
Dr. Brian Cain, M.D is a Internal Medicine healthcare provider based in Concord, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083733273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Cain, M.D has received a total of $2,774 in payments from pharmaceutical and medical device companies, with $145.82 received in 2024. These payments were reported across 182 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,742).
As a Medicare-enrolled provider, Cain has provided services to 1,630 Medicare beneficiaries, totaling 2,386 services with total Medicare billing of $114,193. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics, Internal Medicine
- Location Concord, NC
- Active Since 03/28/2007
- Last Updated 04/17/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083733273
Products in Payments
- Saxenda (Drug) $272.59
- TRULICITY (Drug) $203.73
- FARXIGA (Drug) $201.17
- CHANTIX (Drug) $170.61
- SYMBICORT (Drug) $169.14
- Victoza (Drug) $120.31
- Belviq (Drug) $104.53
- BEVESPI AEROSPHERE (Drug) $96.23
- Wegovy (Drug) $89.59
- Ozempic (Drug) $81.56
- JANUVIA (Drug) $74.41
- JARDIANCE (Drug) $66.23
- Cologuard Collection Kit (Device) $63.46
- BREO (Drug) $50.75
- TOUJEO (Drug) $46.09
- Tresiba (Drug) $44.94
- SOLIQUA (Drug) $44.66
- ANORO (Drug) $39.06
- Myrbetriq (Drug) $37.79
- PRADAXA (Drug) $36.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Concord
Stephen Zouzoulas, Md, MD
Internal Medicine — Payments: $217,825
Internal Medicine $217,825
Manish Jain, Md, MD
Internal Medicine — Payments: $183,163
Internal Medicine $183,163
Dr. Roy Kaplan, M.d, M.D
Internal Medicine — Payments: $139,568
Internal Medicine $139,568
Dr. Anna Chang, M.d, M.D
Internal Medicine — Payments: $110,107
Internal Medicine $110,107
Santosh Rao, Md, MD
Internal Medicine — Payments: $44,301
Internal Medicine $44,301
Steven Park, Md, MD
Internal Medicine — Payments: $26,721
Internal Medicine $26,721